There is a danger of new corona variants in the world, now these companies will make vaccine

There is a danger of new corona variants in the world, now these companies will make vaccine

New Delhi: Novavax Inc said on Friday that it has started work on making corona vaccines against variants found in South Africa. It will start testing and manufacturing in the next few weeks. The company’s corona shot contains the real version of the virus’s spike protein, which cannot cause disease, but can boost the immune system. The vaccine developer said it has begun developing the spike protein, based specifically on the known genetic sequences of the variants. A spokesperson for the company said: “The work on AramBink will take a few weeks.”

On Friday, the company’s shares closed with a gain of about 9 percent. The Novavax vaccine was first allowed for emergency use in Indonesia and then in the Philippines earlier this month. The company has said that it will apply for approval from the US by the end of the year. The company has applied for approval from the European Medicines Agency as well as in Canada. Other vaccine developers, including Germany’s Biotech SE and Johnson & Johnson, have reported that they are testing the effectiveness of their shots against the new version. The new variant has been named Omicron by the World Health Organization.

Inovio Pharmaceuticals Inc. claims that:-

Inovio Pharmaceuticals Inc. said it has started testing its vaccine INO-4800 to evaluate effectiveness against the new variant. The company expects that it will take two weeks in the trial. Inovio also said it was simultaneously designing a new vaccine, specifically targeting Omicron. “The best-case scenario would be the Inovio-4800 being completely dominant against Omicron,” said Kate Broderick, Inovio’s senior vice president of R&D division. If it doesn’t, we’ll have a newly designed vaccine when the need arises.


You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *